Related Experiment Video
Updated: Jul 11, 2026

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
Published on: March 8, 2018
STAT nuclear translocation: potential for pharmacological intervention
1Philipps-Universität Marburg, Klinik für Kardiologie und Klinik für Psychosomatische Medizin und Psychotherapie, Baldingerstrasse 1, 35033 Marburg, Germany. meyert@med.uni-marburg.de
Abstract:
The signal transducer and activator of transcription (STAT) proteins are extracellular ligand-responsive transcription factors that mediate broadly diverse biological processes, including cell proliferation, transformation, apoptosis, differentiation, fetal development, inflammation and immune response. Stimulation with multiple cytokines or growth factors all result in the tyrosine phosphorylation of STAT proteins and the subsequent gene regulation via their direct binding to the promoters of responsive genes. Cytokine-regulated gene activation is dependent on the continuous nucleocytoplasmic cycling of STAT signal transducers. The STATs use intricately intertwined karyopherin-dependent and -independent translocation mechanisms to coordinate the activation step at the cell membrane and gene expression in the nucleus. In addition, STATs appear to have cytokine-independent gene regulatory functions that may also depend on their regulated nucleocytoplasmic transfer. Numerous studies have implicated aberrant STAT signalling in cancer, immune defects and inflammatory diseases. Given the central role of intracellular trafficking for the proper signal processing by STAT proteins, pharmacological targeting of STAT nucleocytoplasmic translocation appears to be an attractive strategy to interfere with dysregulated cytokine signalling. This review will discuss possible scenarios that would result from the use of novel modulators of STAT shuttling, which may both increase or decrease STAT activation and, hence, transcriptional activity.
Insights
Signal transducer and activator of transcription (STAT) proteins regulate gene expression. Modulating STAT protein transport between the nucleus and cytoplasm offers a therapeutic strategy for diseases linked to aberrant STAT signaling.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Signal transducer and activator of transcription (STAT) proteins are crucial transcription factors mediating diverse biological processes.
- STAT protein activation involves tyrosine phosphorylation upon stimulation by cytokines or growth factors, leading to gene regulation.
- Aberrant STAT signaling is implicated in various diseases, including cancer, immune disorders, and inflammatory conditions.
Purpose of the Study:
- To review the role of STAT protein nucleocytoplasmic translocation in cellular signaling.
- To explore the potential of targeting STAT shuttling as a therapeutic strategy for STAT-dysregulated diseases.
- To discuss the implications of modulating STAT activation and transcriptional activity.
Main Methods:
- Review of existing literature on STAT protein function, signaling pathways, and intracellular trafficking.
- Analysis of karyopherin-dependent and -independent translocation mechanisms.
- Discussion of pharmacological approaches to modulate STAT nucleocytoplasmic transport.
Main Results:
- STAT proteins shuttle continuously between the nucleus and cytoplasm, a process essential for cytokine-regulated gene activation.
- STAT proteins possess cytokine-independent gene regulatory functions dependent on their nucleocytoplasmic transfer.
- Targeting STAT nucleocytoplasmic translocation presents a promising strategy to interfere with dysregulated cytokine signaling.
Conclusions:
- Modulators of STAT shuttling could offer novel therapeutic interventions for diseases driven by aberrant STAT signaling.
- Pharmacological targeting of STAT translocation may lead to increased or decreased STAT activation, offering versatile therapeutic potential.
- Understanding STAT intracellular trafficking is key to developing effective treatments for a range of human diseases.
Related Concept Videos
Regulation of Nuclear Protein Sorting
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Nuclear Localization Signals and Import
Nuclear Protein Sorting
Proteins targeted to the nucleus carry nuclear localization signals or NLS recognized by import receptors in the cytosol. Similarly, proteins with nuclear export signals are recognized by export receptors. Import and export receptors are...
Signal Transduction: Overview
Typically, signal transduction involves three...
